These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Eosinophils and Kounis hypersensitivity associated syndrome as contributors to very late coronary stent thrombosis. Kounis NG Int J Cardiol; 2013 Jul; 167(2):594-5. PubMed ID: 23084109 [No Abstract] [Full Text] [Related]
7. In-stent restenosis after revascularization of myocardium with drug-eluting stents is accompanied by elevated level of blood plasma eosinophil cationic protein. Gabbasov ZA; Kozlov SG; Imaeva AE; Saburova OS; Zykov KA; Masenko VP; Smirnov VN Can J Physiol Pharmacol; 2011 Jun; 89(6):413-8. PubMed ID: 21751895 [TBL] [Abstract][Full Text] [Related]
8. [Role of eosinophil granulocytes in the occurrence of restenosis in patients after coronary stenting with drug-eluting stents]. Gabbasov ZA; Kozlov SG; Imaeva AÉ; Saburova OS; Masenko VP Ter Arkh; 2014; 86(9):90-6. PubMed ID: 25518512 [TBL] [Abstract][Full Text] [Related]
9. [Eosinophilic cation protein and development of restenosis of drug covered stents]. Gabbasov ZA; Kozlov SG; Saburova OS; Imaeva AÉ; Bosykh EG; Liakishev AA; Zykov KA; Masenko VP Kardiologiia; 2011; 51(6):49-54. PubMed ID: 21878071 [TBL] [Abstract][Full Text] [Related]
10. Permanent polymer of drug eluting stents increases eosinophil cationic protein levels following percutaneous coronary intervention independently of C-reactive protein. Niccoli G; Calvieri C; Minelli S; Copponi G; Montone RA; Imaeva A; Roberto M; Cosentino N; Crea F Atherosclerosis; 2014 Dec; 237(2):816-20. PubMed ID: 25463127 [TBL] [Abstract][Full Text] [Related]
11. Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents. Niccoli G; Schiavino D; Belloni F; Ferrante G; La Torre G; Conte M; Cosentino N; Montone RA; Sabato V; Burzotta F; Trani C; Leone AM; Porto I; Pieroni M; Patriarca G; Crea F Eur Heart J; 2009 Jun; 30(11):1340-7. PubMed ID: 19383735 [TBL] [Abstract][Full Text] [Related]
17. Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in disease. Yousefi S; Simon D; Simon HU Curr Opin Immunol; 2012 Dec; 24(6):736-9. PubMed ID: 22981682 [TBL] [Abstract][Full Text] [Related]
18. Kounis syndrome: A concise review with focus on management. Fassio F; Losappio L; Antolin-Amerigo D; Peveri S; Pala G; Preziosi D; Massaro I; Giuliani G; Gasperini C; Caminati M; Heffler E Eur J Intern Med; 2016 May; 30():7-10. PubMed ID: 26795552 [TBL] [Abstract][Full Text] [Related]
19. Stent dislodgement induced by a vasodilator used for severe coronary artery spasm caused by Kounis syndrome. Nishi M; Zen K; Kambayashi D; Asada S; Yamaguchi S; Tatsukawa H Cardiovasc Interv Ther; 2016 Jan; 31(1):61-4. PubMed ID: 25652245 [TBL] [Abstract][Full Text] [Related]
20. Kounis syndrome: a potential cause of simultaneous multivessel coronary spasm and thrombosis after drug-eluting stent implantation. Kounis NG; Kounis GN; Soufras GD J Invasive Cardiol; 2007 Apr; 19(4):200-1; author reply 201. PubMed ID: 17404409 [No Abstract] [Full Text] [Related] [Next] [New Search]